Andrew Walding
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Biological Psychiatry top 10%
Papers in
-
- Lung Cancer Treatments and Mutations 16
- Advanced Breast Cancer Therapies 7
- Gastric Cancer Management and Outcomes 3
- Oncology 10
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- David L. Laughton (2 shared papers)Sabina Alam (1 shared paper)Adrian J. Wolstenholme (1 shared paper)Myung‐Ju Ahn (2 shared papers)Hideo Saka (1 shared paper)Sundar Ramalingam (2 shared papers)Kōichi Goto (1 shared paper)Helena A. Yu (1 shared paper)
- Journals
- Journal of Thoracic Oncology (5 papers)Cancer Research (3 papers)European Journal of Cancer (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Molecular Immunology (2 papers)
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
Andrew Walding
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 601
- Biological Psychiatry 40
- Oncology 419
- Cancer Research 91
- Immunology 121
Countries citing papers authored by Andrew Walding
This map shows the geographic impact of Andrew Walding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Walding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Walding more than expected).
Fields of papers citing papers by Andrew Walding
This network shows the impact of papers produced by Andrew Walding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Walding. The network helps show where Andrew Walding may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Walding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 197 | |
| 2 | 2005 | 132 | |
| 3 | 2021 | 118 | |
| 4 | 2018 | 107 | |
| 5 | 2021 | 100 | |
| 6 | 2004 | 91 | |
| 7 | 2020 | 62 | |
| 8 | 2007 | 53 | |
| 9 | 2022 | 51 | |
| 10 | 2019 | 49 | |
| 11 | 2009 | 28 | |
| 12 | 2010 | 26 | |
| 13 | 2021 | 22 | |
| 14 | 2013 | 22 | |
| 15 | 2008 | 20 | |
| 16 | 2022 | 12 | |
| 17 | 2018 | 12 | |
| 18 | 2010 | 10 | |
| 19 | 2017 | 9 | |
| 20 | 2022 | 8 |
About Andrew Walding
Andrew Walding is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Physiology and Genetics, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Gastric Cancer Management and Outcomes (3 papers), Metabolism, Diabetes, and Cancer (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (601 citations), Biological Psychiatry (40 citations), Oncology (419 citations), Cancer Research (91 citations) and Immunology (121 citations). Andrew Walding has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include David L. Laughton, Sabina Alam, Adrian J. Wolstenholme, Myung‐Ju Ahn, Hideo Saka, Sundar Ramalingam, Kōichi Goto, Helena A. Yu, Seung‐Whan Kim and Lulu Yang. Their work appears in journals such as Journal of Thoracic Oncology, Cancer Research, European Journal of Cancer, Bioorganic & Medicinal Chemistry Letters and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.